bell
The current prices are delayed by 15 mins, login to check live prices.
Caplin Point Laboratories Ltd share price logo

Caplin Point Laboratories Ltd

(CAPLIPOINT)

₹2399.1▲0.08%

as on 04:01PM, 26 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Caplin Point Laboratories Ltd Analyst Rating

based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts offering long term price targets for Caplin Point Laboratories Ltd. An average target of ₹2396.67

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Share analysis

Caplin Point Laboratories Ltd price forecast by 3 analysts

Downside of-0.02%

High

₹2510

Target

₹2396.67

Low

₹2280

Caplin Point Laboratories Ltd target price ₹2396.67, a slight downside of -0.02% compared to current price of ₹2399.1. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Performance

  • Day's Low

    Day's High

    ₹2,373.05
    Day's Price Range
    ₹2,412.95

  • 52 Week's Low

    52 Week's High

    ₹1,225
    52-Week Price Range
    ₹2,539.85
1 Month Return+ 13.4 %
3 Month Return+ 24.97 %
1 Year Return+ 68.68 %
Previous Close₹2,397.15
Open₹2,410.00
Volume71.63K
Upper Circuit-
Lower Circuit-
Market Cap₹18,221.14Cr

Caplin Point Laboratories Ltd Key Statistics

P/E Ratio36.88
PEG Ratio3.71
Market Cap₹18,221.14 Cr
P/B Ratio7.2
EPS60.75
Dividend Yield0.38
SectorPharmaceuticals
ROE22.43

Caplin Point Laboratories Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Caplin Point Laboratories Ltd
Caplin Point Laboratories Ltd
BUY₹18,221.14 Cr138.73%0.50₹461 Cr₹1,694 Cr
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd
BUY₹28,426.00 Cr112.52%0.52₹300 Cr₹1,051 Cr
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
BUY₹17,481.58 Cr28.58%0.57₹72 Cr₹6,702 Cr
Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd
NA₹6,532.30 Cr5.83%0.79-₹388 Cr₹75 Cr
Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Ltd
BUY₹15,623.72 Cr48.35%0.68₹218 Cr₹1,296 Cr
See all

Caplin Point Laboratories Ltd Mutual Fund Holdings

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Limited was founded in the year 1990 and is a fully integrated transnational pharmaceutical company. With over 4000 product registrations covering 36 therapeutic segments, the company has set up its presence in 23 countries. It specializes in producing and marketing of wide range of generic formulations and branded products and exporting them to markets like the US, European Union, Africa, LATAM and others. The company has also established a trading branch in Nairobi Kenya and a warehouse in Miami USA in collaboration with Lockett Corp. It completed splitting its shares in 2016 from Rs. 10 to Rs. 2 each. As on date, the company has three subsidiaries in India, Hong Kong and Colombia. It invested in Argus Salud Pharma LLP and set up a Joint venture in China. It also ventured into the ecommerce space. In the year 2021, the company has already received four ANDA approvals and 8 product launches. It has planned to file more 18 ANDAs with an addressable market size of USD 1.95 billion and is investing a sum of Rs. 140 crores in setting up its second Injectable Plant with 2 Vial lines, a Lyophilizer line and a Pre filled syringe line.

Share Price: ₹2399.10 per share as on 26 Dec, 2024 04:01 PM
Market Capitalisation: ₹18,221.14Cr as of today
Revenue: ₹483.10Cr as on September 2024 (Q3 24)
Net Profit: ₹130.81Cr as on September 2024 (Q3 24)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
OrganisationCaplin Point Laboratories Ltd
HeadquartersChennai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Caplin Point Laboratories Ltd

  • Caplin Point Hits 52-Week High After USFDA Approval - 17 Dec, 2024

    Caplin Point Laboratories shares surged 4.9% to a 52-week high of ₹2,539.85 following USFDA approval for its generic drug Difluprednate Ophthalmic Emulsion. The stock has gained 26% in the past month and 93% over the past year.

  • Caplin Point Secures USFDA Approval for Eye Drops - 16 Dec, 2024

    Caplin Point Laboratories' subsidiary, Caplin Steriles, has received USFDA approval for its generic Difluprednate eye drops, enhancing its product portfolio and market presence.

Insights on Caplin Point Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.36% to 3.70% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, CAPLIPOINT stock has moved up by 13.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 12 quarters, 74.95 Cr → 130.8 Cr (in ₹), with an average increase of 4.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 17 quarters, 269.88 Cr → 503.87 Cr (in ₹), with an average increase of 3.8% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.32% to 1.62% in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.56% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 24.57% to 23.90% in Sep 2024 quarter

Caplin Point Laboratories Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹410.06Cr (-)₹435.50Cr (↑6.20%)₹453.22Cr (↑4.07%)₹458.96Cr (↑1.27%)₹483.10Cr (↑5.26%)
Net Income₹116.14Cr (-)₹119.82Cr (↑3.17%)₹121.23Cr (↑1.18%)₹124.92Cr (↑3.04%)₹130.81Cr (↑4.72%)
Net Profit Margin28.32% (-)27.51% (↓2.86%)26.75% (↓2.76%)27.22% (↑1.76%)27.08% (↓0.51%)
Value in ₹ crore
Details2021202220232024
Total Assets₹860.99Cr (-)₹1,054.16Cr (↑22.44%)₹1,303.18Cr (↑23.62%)₹1,522.31Cr (↑16.82%)
Total Liabilities₹102.32Cr (-)₹123.51Cr (↑20.71%)₹163.27Cr (↑32.19%)₹132.16Cr (↓19.05%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹87.01Cr (-)₹294.64Cr (↑238.63%)₹230.97Cr (↓21.61%)₹157.10Cr (↓31.98%)₹111.01Cr (↓29.34%)

Index Inclusions

S&P BSE 250 SmallCap

₹7,049.73

-0.05 (▲-3.4%)

BSE 500

₹35,265.03

0.12 (▲42.38%)

S&P BSE 400 MidSmallCap

₹12,120.29

0.05 (▲5.7%)

BSE Healthcare

₹44,289.95

0.45 (▲197.91%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Nifty Smallcap 250

₹17,667.45

-0.03 (▲-5%)

Nifty MidSmallcap 400

₹19,916.55

0.04 (▲7.65%)

Nifty 500

₹22,430.35

0.12 (▲27.65%)

BSE Small-Cap

₹54,893.21

-0.24 (▲-129.96%)

Caplin Point Laboratories Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
70.56%
0.00
Foreign Institutions
3.7%
10.23
Mutual Funds
1.62%
22.97
Retail Investors
23.9%
-2.74
Others
0.22%
14.98

Caplin Point Laboratories Ltd Key Indicators

Details20202021202220232024
Return On Equity %38.32322.2422.6322.43
Details20202021202220232024
Return On Assets %31.128.1428.4428.8730.03
Details20202021202220232024
Book Value Per Share (₹)96.68128.12167.2219.22276.38
Details20202021202220232024
Earning Per Share (₹)28.4333.2440.6949.6760.75

Caplin Point Laboratories Ltd Valuation

Caplin Point Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.76x)

March 24, 2020

Today (36.88x)

December 24, 2024

Industry (56.56x)

December 24, 2024

Highest (38.00x)

December 11, 2024

LowHigh

Caplin Point Laboratories Ltd Earnings and Dividends

  • Caplin Point Laboratories Ltd Earnings Results

    Caplin Point Laboratories Ltd’s net profit jumped 13.87% since last year same period to ₹130.80Cr in the Q2 2024-2025. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 5.51% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Caplin Point Laboratories Ltd Dividends August,2024

    In the quarter ending June 2024, Caplin Point Laboratories Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.31%.

    Read More about Dividends

Caplin Point Laboratories Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Caplin Point Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Caplin Point Laboratories Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Caplin Point Laboratories Ltd shares.

Caplin Point Laboratories Ltd (CAPLIPOINT) share price today is ₹2399.1

Caplin Point Laboratories Ltd is listed on NSE

Caplin Point Laboratories Ltd is listed on BSE

  • Today’s highest price of Caplin Point Laboratories Ltd is ₹2412.95.
  • Today’s lowest price of Caplin Point Laboratories Ltd is ₹2373.05.

PE Ratio of Caplin Point Laboratories Ltd is 36.88

PE ratio = Caplin Point Laboratories Ltd Market price per share / Caplin Point Laboratories Ltd Earnings per share

Today’s traded volume of Caplin Point Laboratories Ltd(CAPLIPOINT) is 71.63K.

Today’s market capitalisation of Caplin Point Laboratories Ltd(CAPLIPOINT) is ₹18221.14Cr.

Caplin Point Laboratories Ltd(CAPLIPOINTPrice
52 Week High
₹2539.85
52 Week Low
₹1225

Caplin Point Laboratories Ltd(CAPLIPOINT) share price is ₹2399.1. It is down -5.54% from its 52 Week High price of ₹2539.85

Caplin Point Laboratories Ltd(CAPLIPOINT) share price is ₹2399.1. It is up 95.84% from its 52 Week Low price of ₹1225

Caplin Point Laboratories Ltd(CAPLIPOINTReturns
1 Day Returns
1.95%
1 Month Returns
13.4%
3 Month Returns
24.97%
1 Year Returns
68.68%